Position in CDNA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$15,646
+$6,116 QoQ
Shares Held
549
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#194
of 225 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $409,722,218 across 30 Diagnostics & Research names. CDNA ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
418,112 | $209,624,632 | |
| 2 | DHR |
Danaher Corp /De/
|
490,600 | $93,449,488 | |
| 3 | LH |
Labcorp Holdings Inc.
|
56,072 | $15,700,160 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
75,487 | $14,585,598 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
22,624 | $11,910,178 | |
| 6 | A |
Agilent Technologies, Inc.
|
61,882 | $8,219,786 | |
| 7 | GH |
Guardant Health, Inc.
|
51,904 | $7,787,157 | |
| 8 | DGX |
Quest Diagnostics Inc
|
32,540 | $6,896,853 |
All Filings in CDNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,646 | 549 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $9,530 | 549 | Shares | Defined | 2026-05-01 | |
| 2023-06-30 | $14,365 | 1,690 | Shares | Defined | 2023-07-26 | |
| 2022-09-30 | $6,688 | 393 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $9,129 | 425 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $16,349 | 442 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $19,829 | 436 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $20,848 | 329 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $8,511 | 93 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||